Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

OPGN

OpGen (OPGN)

OpGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPGN
DateTimeSourceHeadlineSymbolCompany
03/25/20214:01PMGlobeNewswire Inc.OpGen Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
03/11/20217:30AMGlobeNewswire Inc.OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2020NASDAQ:OPGNOpGen Inc
03/08/20217:30AMGlobeNewswire Inc.OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of Bacterial Co-Infections in ICU Patie...NASDAQ:OPGNOpGen Inc
03/05/20214:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
03/05/20214:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
03/01/20217:30AMGlobeNewswire Inc.OpGen Wins Chinese NMPA Approval for the Curetis Unyvero SystemNASDAQ:OPGNOpGen Inc
02/24/202111:29AMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:OPGNOpGen Inc
02/16/20217:30AMGlobeNewswire Inc.OpGen Subsidiary Ares Genetics Announces Publication of Study Introducing Best Practice Techniques for AI-powered Prediction ...NASDAQ:OPGNOpGen Inc
02/11/20216:10AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OPGNOpGen Inc
02/10/20215:27PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
02/09/20218:30AMGlobeNewswire Inc.OpGen, Inc. Announces $25 Million Registered Direct Offering Priced At-the-Market Under NASDAQ RulesNASDAQ:OPGNOpGen Inc
01/13/20214:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
01/13/20217:30AMGlobeNewswire Inc.OpGen Announces Preliminary Unaudited Revenue for Fiscal 2020 and Provides Business UpdateNASDAQ:OPGNOpGen Inc
01/05/20217:30AMGlobeNewswire Inc.OpGen Subsidiary Curetis and Annar Enter into Unyvero Distribution Partnership for ColombiaNASDAQ:OPGNOpGen Inc
12/17/20208:00AMGlobeNewswire Inc.Results from 1,400 Patient Sample Multicenter Study Published: Unyvero LRT BAL Panel Provides Accurate Detection in Bronchoal...NASDAQ:OPGNOpGen Inc
12/09/20207:30AMGlobeNewswire Inc.OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares GeneticsNASDAQ:OPGNOpGen Inc
12/08/20205:29PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPGNOpGen Inc
12/07/20206:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OPGNOpGen Inc
12/04/20201:46PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:OPGNOpGen Inc
12/01/20207:30AMGlobeNewswire Inc.OpGen Group Company Ares Genetics Advances ares-genetics.cloud Platform, Presents Update at Scientific Conferences, Expects G...NASDAQ:OPGNOpGen Inc
11/24/20205:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
11/24/20208:00AMGlobeNewswire Inc.OpGen, Inc. Announces $10 Million Private Placement Priced at the MarketNASDAQ:OPGNOpGen Inc
11/16/20204:22PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPGNOpGen Inc
11/13/20204:56PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPGNOpGen Inc
11/12/20207:30AMGlobeNewswire Inc.OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Testing Service for Native Specimens ...NASDAQ:OPGNOpGen Inc
11/12/20206:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
11/11/20204:05PMGlobeNewswire Inc.OpGen Reports Third Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
11/02/20204:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
10/29/20207:30AMGlobeNewswire Inc.OpGen to Provide Business Update and Financial Results for the Third Quarter 2020NASDAQ:OPGNOpGen Inc
10/28/20207:30AMGlobeNewswire Inc.OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and CollaboratorsNASDAQ:OPGNOpGen Inc
 Showing the most relevant articles for your search:NASDAQ:OPGN